Ingredion Cuts Full-Year Guidance as Q3 Operating Income Falls 19%
INGR is trading near its 52-week low of $93.3 (1.6% below the low) on elevated volume (2.9× avg).
Summary
Ingredion reported Q3 adjusted EPS of $2.28, down from $2.75, and cut full-year adjusted EPS guidance to $9.25-$9.70 as Argo plant costs and soft demand hit the U.S./Canada unit. Adjusted operating income is now expected down mid-teens for 2026.
Key Events · Earnings and Guidance · INGR
-
Q3 Earnings Miss and Guidance Cut
Third quarter reported and adjusted operating income both fell 19% to $201M and $206M; adjusted diluted EPS was $2.28 versus $2.75 a year ago. Full-year adjusted diluted EPS guidance is now $9.25-$9.70.
-
U.S./Canada Unit Drives the Damage
Food & Industrial Ingredients U.S./CAN operating income fell 36% to $52M on higher Argo manufacturing costs and volume declines; full-year segment operating income is now guided down 35-40%.
-
Cash Flow Outlook Lowered
Full-year 2026 cash from operations is now expected at $650M-$750M, against capital expenditures still guided at roughly $450M-$490M.
-
Tate & Lyle Integration Continues
The $3.5B pending acquisition remains in integration planning; acquisition and integration costs were $6M in the quarter and $59M year-to-date.
Analysis · INGR · Manufacturing
Ingredion missed its own expectations and lowered the full-year outlook, with adjusted operating income now guided down mid-teens instead of prior expectations. The damage is concentrated in Food & Industrial Ingredients U.S./CAN, where operating income fell 36% to $52M on higher Argo plant manufacturing costs, and full-year segment profit there is now guided down 35-40%. Adjusted diluted EPS of $2.28 for the quarter was well below $2.75 a year ago, and the new $9.25-$9.70 full-year adjusted EPS range is a real cut, not a rounding tweak. With the stock already trading near its 52-week low, this removes the hope that the Argo cost problem was behind the company. The pending $3.5B Tate & Lyle acquisition still hangs over the story: integration planning continues, but the core business is generating less cash to support it, with full-year operating cash flow now guided to $650M-$750M.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, INGR was trading at $91.80 on NYSE in the Manufacturing sector, with a market capitalization of approximately $6.1B. The 52-week trading range was $93.30 to $123.49. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.